Curtis K Argo
Overview
Explore the profile of Curtis K Argo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1689
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Henry Z, Argo C
Clin Liver Dis
. 2024 Nov;
29(1):135-147.
PMID: 39608953
Management of cirrhosis sequelae is critical in providing the most options for patients with hepatocellular carcinoma (HCC). Compensated liver disease is the ideal state for HCC patients who may require...
2.
Zaver H, Rajpal N, Shah N, Argo C
Am J Gastroenterol
. 2024 Mar;
119(10):1951-1954.
PMID: 38477457
No abstract available.
3.
Khanna S, Shah N, Argo C
Am J Gastroenterol
. 2023 Oct;
119(4):596-599.
PMID: 37782278
No abstract available.
4.
Dahmus J, Hummer B, Rivas G, Schmitz K, Caldwell S, Argo C, et al.
Dig Dis Sci
. 2023 Jan;
68(6):2695-2703.
PMID: 36692803
Background & Aims: Cardiorespiratory fitness and liver fibrosis are independently associated with poor outcomes in patients with nonalcoholic steatohepatitis (NASH), however, conflicting reports exist about their relationship. We aimed to...
5.
Perez I, Haskal Z, Hogan J, Argo C
World J Hepatol
. 2022 Jun;
14(4):846-853.
PMID: 35646273
Background: Infection of a transjugular intrahepatic portosystemic shunt (TIPS) stent is a rare and serious complication that most commonly occurs during TIPS creation and revision. Patients typically present with recurrent...
6.
Davis J, Miller J, Argo C
Am J Gastroenterol
. 2021 Jun;
116(11):2302.
PMID: 34131084
No abstract available.
7.
Rose J, Vargas P, Seay T, Pesch A, Williams T, Sites A, et al.
Transplant Direct
. 2021 May;
7(6):e702.
PMID: 34056077
Background: Living donor liver transplantation offers an attractive option to reduce the waitlist mortality. However, in recent years, the rising prevalence of obesity and nonalcoholic fatty liver disease has posed...
8.
Stine J, Munaganuru N, Barnard A, Wang J, Kaulback K, Argo C, et al.
Clin Gastroenterol Hepatol
. 2020 Sep;
19(11):2274-2283.e5.
PMID: 32882428
Background & Aims: Magnetic resonance imaging proton density fat fraction (MRI-PDFF) offers promise as a non-invasive biomarker of treatment response in early-phase nonalcoholic steatohepatitis (NASH) trials. We performed a systematic...
9.
Henry Z, Argo C
Gastroenterol Clin North Am
. 2020 Feb;
49(1):45-62.
PMID: 32033764
Non-alcoholic fatty liver disease (NAFLD) figures prominently into the clinical hepatology landscape. NAFLD represents a disease spectrum comprising simple steatosis, steatosis with elevated liver enzymes, and non-alcoholic steatohepatitis (NASH), the...
10.
Davis J, Henry Z, Argo C, Northup P
Clin Liver Dis (Hoboken)
. 2019 Nov;
14(4):156-160.
PMID: 31709046
No abstract available.